H. V. D. Berg

Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: Evaluation of the pilot phase of the PORTEC-4a trial.

T. Bosse, V. Smit, H. Westerveld, 2018, Gynecologic oncology.

Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.

E. M. van der Steen-Banasik, H. Westerveld, M. Nowee, 2020, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.